Monash IVF (ASX:MVF) share price lower despite forecasting strong earnings growth

The Monash IVF Group Ltd (ASX:MVF) share price is trading lower despite forecasting strong earnings growth in the first half…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Monash IVF Group Ltd (ASX: MVF) share price is trading lower following the release of a trading update and its guidance for FY 2021 at its annual general meeting.

In afternoon trade the fertility treatment company's shares are down slightly to 78.2 cents.

Trading update.

According to the release, trading conditions have improved greatly over the last few months.

Management advised that following the COVID impact on its fourth quarter FY 2020 performance, increased demand for its services has led to stimulated cycles growing 23.1% between July and October compared to the prior corresponding period.

This improvement has also been experienced in its international business, with Kuala Lumpur stimulated cycles increasing 16.2% during the period.

One part of the company which wasn't impacted during the pandemic was its Ultrasound businesses. They remained open throughout the pandemic and have continued to perform strongly. For the four months to the end of October, it reported a 10.7% increase in ultrasound scans compared to the prior comparative period.

And while management expects its overall growth to moderate, it remains confident that activity will continue to grow at above historical levels for the remainder of FY 2021. This is based on activity experienced in November and the current patient pipeline, which provides a good indication of activity in the short to medium term.

Though, this remains subject to any COVID-19 developments in the markets it operates in.

FY 2021 guidance.

In light of the above, management expects its first half reported net profit after tax to be approximately $14 million to $14.5 million. This will be up 75% to 81% on the $8.1 million it delivered in the prior comparative period.

Excluding non-regular items, first half net profit after tax is expected to grow 21% to 26% to between $11 million to $11.5 million. Monash IVF's non-regular items include a $3.5 million impact from the Job Keeper Subsidy payments.

Looking to the second half, management expects its earnings growth to slow but still believes it can outperform the prior corresponding period.

It explained: "Earnings growth in 2H21 is expected to moderate as compared to 1H21 following recovery of pent up demand in Q1FY2021, however the Company expects that earnings growth can be achieved in 2H21 (as compared to 2H20) given growth in the current IVF patient pipeline and notwithstanding any further implications from COVID-19."

Finally, this is likely to mean that its dividend payments will begin again.

"Given anticipated earnings growth during FY2021, cash flow and balance sheet positions, the Company is likely to recommence payment of dividends, but remains subject to business performance and any further adverse implications from COVID-19," it added.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A worried man holds his head and look at his computer.
Share Fallers

Why 29Metals, Brainchip, Platinum, and Premier Investments shares are falling today

These ASX shares are having a tough time on hump day.

Read more »

Man with his head in his head because of falling share price.
Share Fallers

Why 29Metals, Atlas Arteria, IDP Education, and Mineral Resources shares are falling

These ASX shares are having a tough time on Tuesday. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why ALS, EOS, NRW, and Patriot Battery Metals are dropping today

These ASX shares are starting the week in the red.

Read more »

A man looking at his laptop and thinking.
Technology Shares

Why are these ASX tech shares getting smashed today?

Owners of these two stocks are missing out today.

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

Why AGL, Brickworks, IGO, and New Hope shares are dropping today

These ASX shares are having a poor session. But why?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Amcor, Arafura, Brainchip, and South32 shares are tumbling today

These ASX shares are having a tough time on hump day. But why?

Read more »

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Share Fallers

Why Aussie Broadband, Liontown, Metals Acquisition, and Seek shares are falling

These ASX shares are having a poor session. But why?

Read more »